TEAD2, a Hippo pathway gene, is somatically mutated in gastric and colorectal cancers with high microsatellite instability

APMIS

Volumn 123, Issue 4, 2015, Pages 359-360

  Je, Eun Mi ^a   Choi, Youn Jin ^a   Chung, Yeun Jun ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Cancers; Hippo pathway; Microsatellite instability; Mutation; TEAD2

Indexed keywords

HISTIDINE; METHIONINE; DNA BINDING PROTEIN; MICROSATELLITE DNA; TEAD2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

COLORECTAL CANCER; DNA SEQUENCE; EXON; FRAMESHIFT MUTATION; GENE; GENETIC ANALYSIS; HUMAN; LETTER; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; STOMACH CANCER; TEAD2 GENE; APOPTOSIS; CELL PROLIFERATION; COLORECTAL TUMOR; GENETICS; SIGNAL TRANSDUCTION; STOMACH TUMOR;

APOPTOSIS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FRAMESHIFT MUTATION; HUMANS; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84925258949     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12327     Document Type: Letter

References (7)

1. Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013;13:246-57.
2. Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development 2011;138:9-22.
3. Harvey K, Tapon N. The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat Rev Cancer 2007;7:182-91.
4. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008;29:673-80.
5. Yoo NJ, Kim HR, Kim YR, An CH, Lee SH. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 2012;60:943-52.
6. Je EM, Kim MR, Min KO, Yoo NJ, Lee SH. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer 2012;131:E1044-7.
7. Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 2012;26:1300-5.